Pharma Focus Asia

Simcere Pharmaceutical Group Announces Research Agreement with Mass General Brigham

Tuesday, June 13, 2023

Simcere Pharmaceutical Group has announced a Sponsored Research Agreement with Mass General Brigham. According to the agreement, up to eight research groups at Mass General Brigham will receive funding for select projects over a period of two years.

The agreement will create a mutually beneficial partnership that advances research and creates new treatment options for cancer patients, autoimmune and central nervous system diseases.

By teaming up with Mass General Brigham, Simcere gains access to the institution's cutting-edge research capabilities and leading clinical expertise. This collaboration is expected to enhance Simcere's global research and development (R&D) efforts, potentially accelerating the discovery and development of innovative therapies.

The Sponsored Research Agreement between Simcere Pharmaceutical Group Limited and Mass General Brigham reflects the commitment in advancing drug development and fostering long-term partnerships. By collaborating with a renowned research institution like Mass General Brigham, Simcere aims to drive innovation and create new treatment options that can benefit patients globally. 

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024